Cambridge Bioscience Named Exclusive Distributor for NanoInk in UK, Ireland | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – NanoInk today announced that Cambridge Bioscience will exclusively distribute its desktop nanofabrication equipment in the UK and Ireland.

The deal includes NanoInk's NLP 2000 System and DPN 5000 System.

Financial terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.